Network origin in Ate van der Zee first degree
Entity | Entity type | Industry | |
---|---|---|---|
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands.
5
| Holding Company | Pharmaceuticals: Other | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ate van der Zee via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Amsterdam | College/University | Doctorate Degree | |
University of Utrecht | College/University | Graduate Degree Graduate Degree | |
University of Groningen | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
VenGen BV
VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Investment Managers | Founder | |
Photonics Healthcare BV
Photonics Healthcare BV Medical SpecialtiesHealth Technology Photonics Healthcare BV engages in the development of medical devices for monitoring mitochondrial function in to clinical practice. It offers Comet monitor, which allows doctors to optically measure the oxygen in the mitochondria inside a patient's cells. The company was founded by Egbert Gezinus Mik, Michael Münker, and Alfred N. Nijkerk in October 2009 and is headquartered in Utrecht, the Netherlands. | Medical Specialties | Founder | |
UbiQ Bio BV
UbiQ Bio BV Pharmaceuticals: MajorHealth Technology UbiQ Bio BV specializes in the ubiquitin related reagents, peptides and assays. The firm focuses on pharma companies and academic research labs. The company was founded by by Huib Ovaa and Farid El Oualidin in 2010 and is headquartered in Amsterdam, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
MeiraGTx Netherlands BV
MeiraGTx Netherlands BV Pharmaceuticals: MajorHealth Technology MeiraGTx Netherlands BV operates as a biopharmaceutical company developing local gene therapy for inflammatory diseases. It is into develop adeno-associated viral mediated gene therapy for patients with rheumatic conditions. The company was founded in 2005 and is headquartered in Amsterdam, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
Netherlands | 12 |
Sectoral
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 3 |
Finance | 2 |
Consumer Non-Durables | 2 |
Operational
Founder | 8 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 4 |
Graduate Degree | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Most connected contacts
Insiders | |
---|---|
Alfred N. Nijkerk | 7 |
Janneke Meulenberg | 6 |
Toos Daemen | 3 |
Hans Nijman | 2 |
Jan C. Wilschut | 1 |
- Stock Market
- Insiders
- Ate van der Zee
- Company connections